What types of cancer use BMT and PBSCT?
BMT and PBSCT are most commonly used in the treatment of leukemia and lymphoma. They are also used in the treatment of childhood brain tumors and neuroblastoma (an uncommon cancer that occurs most often in children). Researchers are evaluating BMT and PBSCT in clinical trials (research studies) for the treatment of various types of cancer, including cancers of the breast and ovary; multiple myeloma; and Wilms’ tumor (a type of kidney cancer that occurs in young children). BMT and PBSCT are often used to treat leukemia that is in remission (the signs and symptoms of cancer have disappeared) and cancers that are not responding to other treatment or have recurred (come back). Return to top of page. • How is the donor’s marrow matched to the patient’s marrow in allogeneic or syngeneic transplantation? To increase the likelihood of successful transplantation and to minimize potential complications, it is important that the transplanted marrow match the patient’s own marrow as closely as pos
